Table 1 Inclusion and exclusion criteria for case selection.
Inclusion criteria |
○ Large B-cell lymphoma with lymphomatous effusion and no antecedent or concurrent solid tumor mass formation ○ Effusion sites: Pleural, peritoneal, and pericardial ○ Lymphoma types ■ Diffuse large B-cell lymphoma (DLBCL) ■ High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements |
Exclusion criteria |
○ Prior or concurrent solid diffuse large B-cell lymphoma (DLBCL) of nodal or extranodal sites, including serosal surfaces of body cavities ○ High suspicion of solid DLBCL from clinical examinations or imaging studies ○ Lymphoma types ■ HHV8 + primary effusion lymphoma (PEL), including solid variant ■ Plasmablastic lymphoma (PBL) ■ Burkitt lymphoma ■ Post-transplant lymphoproliferative disorder, monomorphic DLBCL or PBL type ■ Plasmablastic plasma cell myeloma presenting with body cavity effusions ■ Blastic or pleomorphic mantle cell lymphoma ■ Peripheral T-cell lymphoma or anaplastic large-cell lymphoma ○ Cases with prior or concurrent low-grade B-cell lymphoma ○ Cases lacking HHV8 studies |